ArticleFrontiers in pharmacology2025

Immune-related adverse events with PD-1/PD-L1 inhibitors: insights from a real-world cohort of 2523 patients.

Ting Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.